收藏切换
Design, synthesis and biological evaluation of saccharin-based HDACs inhibitors for the treatment of triple-negative breast cancer
收藏切换
PDF
Xiao-meng LI1, Meng-yao QUAN2, Yu-chen LIU2, Xu-ben HOU2, Lei-qiang HAN1, *, Hao FANG2, *
Acta Pharmaceutica Sinica | 2024, 59(11) : 3017 - 3026
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(11): 3017-3026
Design, synthesis and biological evaluation of saccharin-based HDACs inhibitors for the treatment of triple-negative breast cancer
Full
Xiao-meng LI1, Meng-yao QUAN2, Yu-chen LIU2, Xu-ben HOU2, Lei-qiang HAN1, *, Hao FANG2, *
Affiliations
  • 1. Department of Pharmacy, the Second Hospital of Shandong University, Ji′nan 250033, China
  • 2. School of Pharmaceutical Science, Key Laboratory of Chemical Biology (Ministry of Education), Shandong University, Ji′nan 250012, China
Published: 2024-11-12 doi: 10.16438/j.0513-4870.2024-0562
Outline
收藏切换

As a key epigenetic regulator, histone deacetylases (HDACs) play a crucial role in cancer development. Small molecule HDAC inhibitors have been shown to inhibit tumor proliferation and induce apoptosis, attracting significant research attention. In this study, we designed and synthesized a series of novel saccharin derivatives as HDAC inhibitors. Biological experiments demonstrated that the target compound 9a exhibited superior HDACs inhibition activity to vorinostat and demonstrating promising in vitro and in vivo anti-tumor activity against triple-negative breast cancer (TNBC). All animal experiments in this study were performed in strict accordance with the protocols approved by the Ethical Committee of School of Pharmaceutical Sciences in Shandong University (Approval No. 230094). This work represents an initial exploration of developing saccharin-based HDAC inhibitors, and the active compound 9a could serve as a lead compound for further study.

saccharin  /  histone deacetylase inhibitor  /  anti-tumor  /  triple-negative breast cancer  /  structure-activity relationship
Xiao-meng LI, Meng-yao QUAN, Yu-chen LIU, Xu-ben HOU, Lei-qiang HAN, Hao FANG. Design, synthesis and biological evaluation of saccharin-based HDACs inhibitors for the treatment of triple-negative breast cancer[J]. Acta Pharmaceutica Sinica, 2024 , 59 (11) : 3017 -3026 . DOI: 10.16438/j.0513-4870.2024-0562
Year 2024 volume 59 Issue 11
PDF
161
62
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2024-0562
  • Receive Date:2024-06-17
  • Online Date:2025-11-24
  • Published:2024-11-12
Article Data
Affiliations
History
  • Received:2024-06-17
  • Revised:2024-08-28
Funding
Affiliations
    1. Department of Pharmacy, the Second Hospital of Shandong University, Ji′nan 250033, China
    2. School of Pharmaceutical Science, Key Laboratory of Chemical Biology (Ministry of Education), Shandong University, Ji′nan 250012, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2024-0562
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT